Antipyrine and Benzocaine

ANTIPYRINE AND BENZOCAINE- antipyrine and benzocaine liquid
Preferred Pharmaceuticals, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Topical Decongestant and Analgesic

Rx Only


Antipyrine and Benzocaine Otic Solution is an otic solution containing Antipyrine, Benzocaine, Oxyquinoline Sulfate, and Anhydrous Glycerin for use in the ear. The solution congeals at 0°C (32°F), but returns to normal consistency, unchanged, at room temperature.

Antipyrine is an analgesic with local anesthetic action, it is chemically 2,3-dimethyl-1-phenyl-3-pyrazolin-5- one. The active ingredient is represented by the structural formula:

Chemical Structure

C11H12N2O MW=188.22

C11H12N2O MW=188.22

Antipyrine occurs as colorless crystals or white powder, has a slightly bitter taste and is soluble in water and alcohol.

Benzocaine is a local anesthetic. It is chemically ethyl p-aminobenzoate or Benzoic acid, 4-amino-, ethyl ester. The active ingredient is represented by the structural formula:

Chemical Structure

C9H11NO2 MW=165.19

C9H11NO2 MW=165.19

It occurs as white crystals or white crystalline powder and is slightly soluble in water and soluble in organic solvents.


Actives: Antipyrine 54 mg, Benzocaine 14 mg; Inactives: Glycerine (anhydrous), Oxyquinoline Sulfate.


Antipyrine and Benzocaine Otic Solution combines the hygroscopic property of anhydrous glycerin with the analgesic action of antipyrine and benzocaine to relieve pressure, reduce inflammation and congestion, and to alleviate pain and discomfort in acute otitis media.

Antipyrine and Benzocaine Otic Solution does not blanch the tympanic membrane or mask the landmarks and, therefore, does not distort the otoscopic picture.


Acute Otitis media of various etiologies

prompt relief of pain and reduction of inflammation in the congestive and serous stages.
adjuvant therapy during systemic antibiotic administration for resolution of the infection.

Because of the close anatomical relationship of the eustachian tube to the nasal cavity, otitis media is a frequent problem, especially in children in whom the tube is shorter, wider, and more horizontal than in adults.

Removal of Cerumen

facilitates the removal of excessive or impacted cerumen.


The product is contraindicated in any person with hypersensitivity to any of the components or substances related to them.
This product is contraindicated in the presence of spontaneous perforation of the tympanic membrane or discharge.



Discontinue promptly if sensitization or irritation occurs.


Information for Patients

Avoid contaminating the dropper with material from the ear, fingers or other source.

Carcinogenesis, Mutagenesis, Impairment of Fertility

No long term studies have been conducted.


Category C

Animal reproduction studies have not been conducted with Antipyrine and Benzocaine Otic Solution. It is also not known whether Antipyrine and Benzocaine Otic Solution can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Antipyrine and Benzocaine Otic Solution should be given to a pregnant woman only if clearly needed.

Nursing Mothers

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Antipyrine and Benzocaine Otic Solution is administered to a nursing woman.


Acute otitis media

Instill Antipyrine and Benzocaine Otic Solution, permitting the solution to run along the wall of the ear canal until it is filled. Avoid touching the ear with dropper. Then moisten a cotton pledget with Antipyrine and Benzocaine Otic Solution and insert into meatus. Repeat every one to two hours until pain and congestion are relieved.

Removal of Cerumen

Before: Instill Antipyrine and Benzocaine Otic Solution three times daily for two or three days to help detach cerumen from wall of ear canal and facilitate removal.

After: Antipyrine and Benzocaine Otic Solution is useful for drying out the ear canal or relieving discomfort.

Before and after removal of cerumen, a cotton pledget moistened with Antipyrine and Benzocaine Otic Solution should be inserted into the meatus following instillation.


Antipyrine and Benzocaine Otic Solution is supplied in a plastic light-resistant dropper-bottle with a screwtop cap. Tamper evident seal is on the bottle cap. Do not use if seal is broken.

15mL — 68788-9276-1

Storage and Handling

Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature]. Protect from heat and light. Protect from freezing.

Call your doctor for medical advice about side effects. You may report side effects to 813-283-1344.

Manufactured for:
Virtus Pharmaceuticals, LLC
Tampa, FL 33619

Rev. 04/12

Relabeled by Preferred Pharmaceuticals, Inc.


Antipyrine & Benzocaine

Otic Solution, USP

Each mL Contains the Active Ingredients:

Antipyrine USP 54 mg
Benzocaine USP 14 mg

Rx only
10 mL (1/3 fl. oz.)

Antipyrine & Benzocaine Otic Solution
(click image for full-size original)
antipyrine and benzocaine liquid
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68788-9276(NDC:76439-305)
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Antipyrine (Antipyrine) Antipyrine 54 mg in 1 mL
Benzocaine (Benzocaine) Benzocaine 14 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
Oxyquinoline Sulfate
# Item Code Package Description Multilevel Packaging
1 NDC:68788-9276-1 1 BOTTLE, DROPPER in 1 CARTON contains a BOTTLE, DROPPER
1 15 mL in 1 BOTTLE, DROPPER This package is contained within the CARTON (68788-9276-1)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved drug other 02/23/2015
Labeler — Preferred Pharmaceuticals, Inc. (791119022)
Registrant — Preferred Pharmaceuticals, Inc. (791119022)
Name Address ID/FEI Operations
Preferred Pharmaceuticals, Inc. 791119022 RELABEL (68788-9276)

Revised: 02/2015 Preferred Pharmaceuticals, Inc.

All resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.